SCEMBLIX

Indicated For

Chronic myeloid leukemia (CML)

About This Medication

# Novartis Patient Support Patient Guide: How to Get SCEMBLIX (asciminib) at Low or No Cost SCEMBLIX (asciminib) is a prescription medication used to treat certain adults with **Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)** in chronic phase, either newly diagnosed or after prior treatments. Novartis Patient Support offers two main paths to make SCEMBLIX more affordable: the **Co-Pay Plus program** for patients with private insurance (helping reduce out-of-pocket copays) and the **Novartis Patient Assistance Foundation (NPAF)** for uninsured or underinsured patients who meet income guidelines, providing free medication.[5][1][2] ## Who Qualifies for Novartis Patient Support? This program helps U.S. residents (including territories) facing high costs for SCEMBLIX. Eligibility splits into two tracks: - **Co-Pay Plus (for privately insured patients)**: Covers copays, coinsurance, or deductibles. Not available if you're enrolled in Medicare, Medicaid, TRICARE, VA, DoD, or other federal/state programs. Patients must have commercial/private insurance.[5] - **NPAF (for uninsured/underinsured)**: Free SCEMBLIX for patients with limited or no prescription coverage who meet income guidelines. You must reside in the U.S., have a valid prescription from a licensed U.S. provider, and be treated outpatient.[1][2][4] **Key benefits include**: - Reduced or $0 copays for eligible insured patients. - Free medication shipped for up to 12 months (renewable) via NPAF. - Help with prior authorizations (PAs) and appeals.[5][10] ## About SCEMBLIX (asciminib) SCEMBLIX is a **targeted therapy tablet** taken orally, once daily, that works differently from other CML treatments by directly inhibiting a specific protein (BCR-ABL1) driving cancer cell growth. It's FDA-approved for: - Newly diagnosed Ph+ CML in chronic phase. - Patients whose CML progressed after two or more tyrosine kinase inhibitors (TKIs).[5] **Common side effects** (discuss with your doctor): rash, tiredness, headache, nausea, muscle/joint pain, diarrhea, and low blood counts. Always follow your healthcare provider's instructions. This guide focuses on affordability, not medical advice.[5] ## Income Eligibility Breakdown NPAF requires proof of income based on **Federal Poverty Level (FPL)** guidelines, but exact percentages or thresholds aren't publicly detailed—check www.PAP.Novartis.com or call 800-277-2254 for your medication-specific limits.[1][2][4] Household size is based on your tax return (Form 1040). | Household Size | Estimated Income Threshold (Example: 400% FPL)* | Notes | |---------------|------------------------------------------------|-------| | 1 (Individual) | Up to ~$60,000 | Varies; submit proof like tax returns, pay stubs. | | 2 (Couple) | Up to ~$81,000 | Exact limits on PAP site. | | 3 | Up to ~$102,000 | Proof required for all. | | 4 | Up to ~$123,000 | Larger families get higher limits. | *Hypothetical based on 2026 FPL; **confirm current guidelines** as they update yearly. Income includes all household sources.[1][4] ## Insurance Requirements - **Co-Pay Plus**: Private/commercial insurance only. Excludes government programs like Medicare Part D, Medicaid.[5] - **NPAF**: Limited/no prescription coverage. Submit front/back copies of **all** insurance cards (primary, secondary, Rx). If insured, prove inadequate coverage (e.g., PA denial).[1][2][4] Novartis helps with PAs/appeals using checklists and sample letters.[10] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit support.scemblix.com or PAP.Novartis.com. Use the online tool or call 866-433-8000 (Mon-Fri, 8AM-8PM ET).[5][2] 2. **Gather Documents**: - Proof of income (tax return, W-2, pay stubs, SSI award). - Proof of residency (utility bill, lease). - Valid SCEMBLIX prescription. - Insurance cards (front/back). - Completed enrollment form signed by you **and** your doctor.[1][4] 3. **Enroll** (multiple methods): - **Online**: support.scemblix.com (2-3 minutes for Co-Pay).[5] - **Phone**: 866-433-8000.[5] - **Start Form**: Download from SCEMBLIX site; doctor completes/sends via fax (855-817-2711) or mail (NPAF, PO Box 2529, Columbus, OH 43216).[1][5] 4. **Submit**: Fax/mail complete form. Incomplete apps delay/deny.[1][4] 5. **Follow Up**: Opt-in for texts. Expect outcome letter in ~4 weeks.[2] Your doctor must authorize sharing health info for processing.[1] ## Timeline and Delivery - **Online Co-Pay**: Instant enrollment; benefits apply at pharmacy.[5] - **NPAF**: 4 weeks for decision. If approved, medication ships to doctor's office or home (free).[5][2] - Refills: Annual reapplication or doctor recertification may apply.[2] ## Alternatives if Denied - **Appeal**: Resubmit with missing info or contact support.[1] - **Other Programs**: Check NeedyMeds.org, RxAssist.org, or Partnership for Prescription Assistance. - **State Assistance**: Local Medicaid or charity clinics. - **Manufacturer Appeal**: Call 800-277-2254 for NPAF review.[2][4] - **Generic/Biosimilars**: None currently for asciminib. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Programs can change; **verify details** at official sites or by phone. Not medical/financial advice—consult your doctor and financial advisor. Novartis reserves rights to modify/deny at discretion. Only patients/guardians can enroll.[1][2][5]

Program information last verified: March 30, 2026